Skip to main content

Menu

BNF February 2022 Update

This update contains 9 significant changes, 3 new monographs, 1 new preparation, 1 deleted monograph and 1 deleted preparation.

Significant Changes:

  • Bacillus Calmette-Guérin vaccine: updated guidance for immunisation of neonates in-line with Public Health England/UK Health Security Agency recommendations.
  • Brolucizumab (Beovu®): updated recommendations to minimise the known risk of intraocular inflammation, including retinal vasculitis and/or retinal vascular occlusion [MHRA/CHM advice].
  • COVID-19 vaccines: updated guidance in-line with UK Health Security Agency recommendations.
  • Haloperidol (Haldol®): reminder of risks when used in elderly patients for the acute treatment of delirium [MHRA/CHM advice].
  • Immunisation schedule: updated guidance for immunisation of neonates and adults aged 70-79 years in-line with Public Health England/UK Health Security Agency recommendations.
  • Individual monographs created for herpes-zoster vaccine (recombinant, adjuvanted), herpes-zoster vaccine, live, and varicella-zoster vaccine.
  • Varicella-zoster vaccine: title changed to Varicella-zoster vaccines.
  • Varicella-zoster vaccines : updated guidance for immunisation against herpes zoster in-line with Public Health England/UK Health Security Agency recommendations.
  • Venetoclax (Venclyxto®): updated recommendations on tumour lysis syndrome (TLS) [MHRA/CHM advice].

New Monographs:

  • Shingrix® [herpes-zoster vaccine (recombinant, adjuvanted)].
  • Vazkepa® [icosapent ethyl].
  • Xofluza® [baloxavir marboxil].

New Preparations: Sixmo® [buprenorphine].

Deleted Monographs: Meningococcal group C vaccine.

Deleted Preparations: Cervarix® [human papillomavirus vaccines].

For further details on changes in the BNF click on https://www.medicinescomplete.com/#/content/bnf/PHP107699